| Literature DB >> 29943349 |
Gao-Wei Li1, Han Liu2, Feng Qiu2, Xiao-Juan Wang1, Xin-Xiang Lei3.
Abstract
The determination of natural products stereochemistry remains a formidable task. Residual dipolar couplings (RDCs) induced by anisotropic media are a powerful tool for determination of the stereochemistry of organic molecule in solution. This review will provide a short introduction on RDCs-based methodology for the structural elucidation of natural products. Special attention is given to the current availability of alignment media in organic solvents. The applications of RDCs for structural analysis of some examples of natural products were discussed and summarized. This review provides a short introduction on RDCs-based methodology for the structural elucidation of natural products. Special attention is given to the current availability of alignment media in organic solvents. The applications of RDCs for structural analysis of some examples of natural products were discussed and summarized.Entities:
Keywords: Alignment media; NMR spectroscopy; Natural products; Residual dipolar couplings; Structural elucidation
Year: 2018 PMID: 29943349 PMCID: PMC6102172 DOI: 10.1007/s13659-018-0174-x
Source DB: PubMed Journal: Nat Prod Bioprospect ISSN: 2192-2209
Fig. 1Schematic representation of two nuclear spins connected by the internuclear vector r that encloses an angle θ with respect to the external magnetic field B0; The exact formula for the dipolar coupling D is Eq. (1)
Fig. 2The diagram of two alignment media for RDCs analysis
The different LLC media according to structure types of polymers
| Types of polymers | LLC | Compatible solvents | Chirality | References |
|---|---|---|---|---|
| Polypeptides | PBLG/PBDG | CDCl3, CD2Cl2, DMF, THF, Dioxane | Chiral | [ |
| PCBLL/PCBDL | CDCl3 | Chiral | [ | |
| PELG/PEDG | CDCl3, CD2Cl2 | Chiral | [ | |
| PSMBLG/PSMBDG | CDCl3 | Chiral | [ | |
| PPLA/PPDA | CDCl3,TCE- | Chiral | [ | |
| ACHC-rich β-peptides | D2O | Chiral | [ | |
| AAKLVFF | CD3OD, CD3OD/acetone, CD3OD/DMSO | Chiral | [ | |
| Polyguanidines | ( | CDCl3 | Chiral | [ |
| Polyarylacetylenes (PPA) | L-Ala-based PPA | CDCl3 | Chiral | [ |
| L-Phe-based PPA | CDCl3 | Chiral | [ | |
| L-Val-based PPA | CDCl3 | [ | ||
| Polyarylisocyanides (PPI) | L-Ala-based PPI | CDCl3, CD2Cl2, THF | Chiral | [ |
| Polyisocyanopeptides (PIP) | CDCl3 | [ | ||
| Graphene oxide | GO | D2O-DMSO, D2O-CD3CN, D2O-Acetone | Achiral | [ |
| GO- | DMSO | Achiral | [ | |
| Supramolecules | SaS-LLCs | CDCl3,CDCl3-CCl4, THF | Chiral | [ |
| Others | DSCG | D2O | Achiral | [ |
| C12E5 | D2O | Achiral | [ | |
| C12MPB | D2O | Achiral | [ |
Fig. 31H NMR of estrone in the isotropic (blue) and anisotropic GO-g-TFEMA (red)
Cross-linked polymer gels and their solvent compatibilities and properties
| Gels | Compatible solvents | Chirality | References |
|---|---|---|---|
| Gelatin | D2O | Chiral | [ |
| e−-Gelatin | D2O, DMSO | Chiral | [ |
| Collagen | D2O | Chiral | [ |
| PAA | D2O | Achiral | [ |
| PH | D2O, DMSO, DMF | Achiral | [ |
| APhES-PH | D2O, DMSO, CD3OD | Chiral | [ |
| PAN, dPAN | DMSO, DMF | Achiral | [ |
| PEO | D2O, CD3CN, CD3OD, DMSO, DMAC, acetone, THF, CDCl3, CD2Cl2, C6D6, dioxane, | Achiral | [ |
| PVAc | CDCl3, CD2Cl2, C6D6, CD3OD, CD3CN, DMSO, DMF, acetone, EtOAc, dioxane | Achiral | [ |
| PMMA | CDCl3, CD2Cl2, C6D6, CD3CN, acetone, EtOAc | Achiral | [ |
| PS, dPS | CDCl3, CD2Cl2, THF, C6D6, dioxane | Achiral | [ |
| PDMS | CDCl3, CD2Cl2, THF, C6D6, dioxane, | Achiral | [ |
| PBLG gel | CDCl3, CD2Cl2, THF, C6D6, Dioxane | Chiral | [ |
| p-HEMA | DMSO | Achiral | [ |
| p-DEGMEMA | CD3OD | Achiral | [ |
Fig. 4Spectral region of conventional F2-coupled HSQC (a) and the CLIP-HSQC spectrum (b) of strychnine in CDCl3 for a mismatched delay for heteronuclear coherence transfer
Fig. 5(a) Expanded CLIP-HSQC spectra of strychnine in the isotropic CDCl3 phase (blue contours) and in anisotropic l,l-PIAF-OBn LCs (red contours). The inserted trace from the anisotropic 2D spectra (C11/H32, C12/H33, C13/H34 and C14/H35) illustrates the favorable line widths. (b) Expanded regions of methylene C6/H27 and C6/H28, C18/H38 and C18/H39 signals in the JSB-HSQC experiment for measuring the 1DCH couplings
Fig. 6Correlation between the experimental 1DCH and the back-calculated RDC of triptolide in l,l-PIAF-OBn LCs using the X-ray structure of triptolide/14-epi-triptolide as the input. The RDC fitting was performed with SVD using MSpin software package
Fig. 7Schematic representation of the steps involved in determination of natural product stereochemistry by RDC analysis. (a) Structure of vatiparol (17). (b) Comparison between the gels for 1.7 and 5 mm NMR tubes. (c) The 1DC–H values are extracted as the difference of the splitting between isotopic and anisotropic signals. (d) Comparison of Q factors of eight possible diastereomers by NOE deviations and RDC fitting
Fig. 9Natural product with the stereochemistry assigned by RDC measurements
Fig. 8Comparison of experimentally measured ECD spectrum of fusariumin A (27) to the calculated ones using the RDC determined conformer (both enantiomers)
Natural products stereochemistry applications of RDCs
| Natural products | Source organism | Alignment medium | Year of assignment | Direction of application | References |
|---|---|---|---|---|---|
| Strychnine |
| PBLG/CDCl3, PELG/CDCl3, PS/CDCl3 | 2003–2005 | Prochiral assignment | [ |
| Sodium cholate |
| PAA/D2O | 2003 | Relative configuration | [ |
| Cyclosporin A |
| PDMS/CDCl3 | 2005 | Conformation | [ |
| Sphaeropsidin A |
| PVAc/DMSO | 2005 | Prochiral assignment | [ |
|
| (C12E5)/ | 2006, 2009 | Relative configuration | [ | |
| Hormaomycin |
| PH/DMSO | 2006 | Conformation | [ |
| Sagittamide A |
| PH-PDMAA, PAN/DMSO | 2007 | Relative configuration | [ |
| Ludartin |
| PMMA/CDCl3 | 2008 | Relative configuration | [ |
| Staurosporine |
| dPS/CDCl3 | 2008 | Relative configuration, | [ |
| Cylindramide |
| PAN/DMSO | 2008 | Conformation | [ |
| Archazolide A |
| PH-PDMAA/DMSO | 2008 | Relative configuration, conformation | [ |
| Sucro-neolambertellin | PH-PDMAA, PAN/DMSO | 2008 | Relative configuration | [ | |
| Withanolides |
| PMMA/CDCl3 | 2009 | Absolute configuration | [ |
| Tricyclocohumol | dPAN/DMSO | 2009 | Relative configuration | [ | |
| 10- | PMMA/CDCl3 | 2010 | Relative configuration | [ | |
| (−)-Dibromopalau’amine |
| PAN/DMSO | 2010 | Absolute configuration | [ |
| Parthenolide |
| PAN/DMSO | 2010 | Conformation | [ |
| Fibrosterol sulfate A | dPAN/DMSO | 2011 | Relative configuration | [ | |
| Asperdimin dimer analog | PDMS/CDCl3 | 2011 | Relative and absolute configuration | [ | |
| Vatiparol |
| PH/DMSO | 2012 | Absolute configuration | [ |
| 19-OH-(−)-eburnamonine |
| PMMA/CDCl3 | 2012 | Absolute configuration | [ |
| 4,6-Diacetylhygrophorone A12 |
| PBLG/CD2Cl2 | 2013 | Relative configuration | [ |
| Rifamycin-S |
| PDMS/CDCl3 | 2013 | Relative configuration, conformation | [ |
| Cyclolinopeptide A |
| PDMS/CDCl3 | 2014 | Conformation | [ |
| Melohenine B |
| PBLG/CDCl3 | 2015 | Conformation | [ |
| α-Santonin |
| PAN/DMSO | 2015 | Relative configuration | [ |
| Retrorsine |
| p-HEMA, PMMA/DMSO | 2016 | Conformation | [ |
| Fusariumin A | PH/DMSO | 2016 | Absolute configuration | [ | |
| Dihydroartemisin |
| GO- | 2016 | Absolute configuration | [ |
| Homodimericin A |
| p-HEMA/DMSO | 2016 | Relative configuration | [ |
| β-Caryophyllene |
| PDMS/CDCl3 | 2017 | Conformation | [ |
| Xylorumphiins |
| PMMA/CDCl3 | 2017 | Relative configuration | [ |
| Methylgriselimycin |
| PDMS/CDCl3 | 2017 | Conformation | [ |
| Cryptospirolepine |
| p-HEMA/DMSO | 2017 | Relative configuration | [ |
| Aquatolide |
| p-HEMA/DMSO | 2017 | Relative configuration | [ |
| Ecteinamycin | PMMA/CDCl3 | 2017 | Relative configuration | [ | |
| β-Heptapeptide | β-HXaa | PVAc/CD3OD | 2017 | Relative configuration | [ |
| Gibberellin |
| AAKLVFF/CD3OD | 2017 | Absolute configuration | [ |
| Ingenol | AAKLVFF/CD3OD | 2017 | Absolute configuration | [ | |
| Ginkgolide B |
| AAKLVFF/CD3OD | 2017 | Absolute configuration | [ |
| Actinomycin D | AAKLVFF/CD3OD | 2017 | Absolute configuration | [ | |
| Artemether |
| AAKLVFF/CD3OD | 2017 | Absolute configuration | [ |
| Caulamidine A |
| p-HEMA/CD3CN | 2018 | Absolute configuration | [ |